Universal Beteiligungs und Servicegesellschaft mbH Makes New $936,000 Investment in CorVel Corp. (NASDAQ:CRVL)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in CorVel Corp. (NASDAQ:CRVL) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 8,361 shares of the business services provider’s stock, valued at approximately $936,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. LGT Financial Advisors LLC lifted its stake in shares of CorVel by 200.0% in the fourth quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock worth $28,000 after acquiring an additional 170 shares during the period. Bessemer Group Inc. raised its holdings in CorVel by 6,350.0% during the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider’s stock worth $29,000 after purchasing an additional 254 shares during the last quarter. von Borstel & Associates Inc. acquired a new position in shares of CorVel in the 1st quarter worth approximately $28,000. CIBC Private Wealth Group LLC lifted its position in shares of CorVel by 300.0% in the 4th quarter. CIBC Private Wealth Group LLC now owns 480 shares of the business services provider’s stock worth $53,000 after purchasing an additional 360 shares during the period. Finally, Federated Hermes Inc. boosted its stake in shares of CorVel by 154.9% in the 4th quarter. Federated Hermes Inc. now owns 492 shares of the business services provider’s stock valued at $55,000 after purchasing an additional 299 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

CorVel Trading Down 2.1%

CRVL stock opened at $86.71 on Friday. The firm has a market cap of $4.46 billion, a PE ratio of 47.21 and a beta of 0.98. The stock has a 50-day moving average price of $101.36 and a 200-day moving average price of $108.47. CorVel Corp. has a 1-year low of $86.32 and a 1-year high of $128.61.

CorVel (NASDAQ:CRVL) last released its earnings results on Thursday, May 22nd. The business services provider reported $0.51 EPS for the quarter. The business had revenue of $231.51 million during the quarter. CorVel had a return on equity of 32.55% and a net margin of 10.63%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a research note on Friday, April 18th.

Insider Activity

In other news, Director R Judd Jessup sold 935 shares of CorVel stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $113.50, for a total value of $106,122.50. Following the completion of the sale, the director owned 129,519 shares in the company, valued at $14,700,406.50. The trade was a 0.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Brandon O’brien sold 3,957 shares of the business’s stock in a transaction on Monday, June 9th. The shares were sold at an average price of $108.46, for a total transaction of $429,176.22. Following the transaction, the chief financial officer owned 11,804 shares in the company, valued at $1,280,261.84. The trade was a 25.11% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 13,079 shares of company stock worth $1,446,023. Company insiders own 44.56% of the company’s stock.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.